Related Experiment Video
Updated: Feb 2, 2026
07:27
Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
25.2K
TREATMENT OF CONGENITAL PSEUDARTHROSIS OF THE TIBIA.
Vestnik Khirurgii Imeni I. I. Grekova
|November 21, 2018
Summary
The Ilizarov technique shows promise for treating congenital pseudarthrosis of the tibia. Combined external and internal fixation methods offer a potentially effective approach for patient rehabilitation.
Area of Science:
- Orthopedics
- Pediatric Surgery
- Regenerative Medicine
Background:
- Congenital pseudarthrosis of the tibia is a rare, debilitating condition.
- Current treatment options for this condition have limitations.
- Effective surgical techniques are crucial for improving patient outcomes.
Purpose of the Study:
- To analyze the treatment outcomes of congenital pseudarthrosis of the tibia using the Ilizarov technique.
- To evaluate the efficacy of combined external and internal osteosynthesis in rehabilitating these patients.
Main Methods:
- Retrospective analysis of 47 patients with congenital pseudarthrosis of the tibia.
- Application of the Ilizarov technique for unfree osteoplasty.
- Utilizing combined variants of external and internal osteosynthesis.
Main Results:
- The Ilizarov technique was applied to 47 patients.
- The study focused on the analysis of treatment results.
- Combined osteosynthesis variants were explored for their rehabilitative potential.
Conclusions:
- The Ilizarov technique is a viable option for treating congenital pseudarthrosis of the tibia.
- Combined external and internal osteosynthesis presents a promising strategy for patient rehabilitation.
- Further research into combined fixation methods could enhance treatment efficacy.
Related Concept Videos
01:10Bones of the Lower Limb: Tibia and Fibula
9.3K
The tibia is the main weight-bearing bone of the lower leg. It is larger than the fibula with which it is paired. The tibia is also the second longest bone in the body and is located right below the skin. The proximal end of the tibia forms the medial and the lateral condyle, which articulates with the condyles of the femur to form the knee joint. Between the articulating surfaces is the irregular elevated area known as the intercondylar eminence that serves as the inferior attachment point for...
9.3K
01:27Open Angle Glaucoma: Treatment
996
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
996
02:56Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
01:24Parkinson's Disease: Treatment
1.2K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K
01:22Alzheimer's Disease: Treatment
956
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
956
01:26Anticholinesterase Agents: Poisoning and Treatment
1.6K
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.6K